STATINS AND MYOPATHY: MOLECULAR MECHANISMS
نویسندگان
چکیده
منابع مشابه
Cellular and Molecular Mechanisms Underlying Congenital Myopathy-related Weakness
Lindqvist, J. 2014. Cellular and Molecular Mechanisms Underlying Congenital Myopathy-related Weakness. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 977. 45 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-554-8894-9. Congenital myopathies are a rare and heterogeneous group of diseases. They are primarily characterised by skeletal muscle weakness ...
متن کاملStatins: mechanisms of neuroprotection.
Clinical trials report that the class of drugs known as statins may be neuroprotective in Alzheimer's and Parkinson's disease, and further trials are currently underway to test whether these drugs are also beneficial in multiple sclerosis and acute stroke treatment. Since statins are well tolerated and have relatively few side effects, they may be considered as viable drugs to ameliorate neurod...
متن کاملVascular Aging and Diseases: Molecular Mechanisms and Influences
Vascular aging plays an important role in the mortality of the elderly, but vascular aging can be dependent on other factors such as diseases. Various diseases such as Alzheimer, diabetes, thalassemia, and other diseases affect the mechanisms of vascular aging. It will harm the recovery process of these patients. There are methods for measuring vascular aging such as instrumental measurements a...
متن کاملAlcoholic Myopathy: Pathophysiologic Mechanisms and Clinical Implications
Skeletal muscle dysfunction (i.e., myopathy) is common in patients with alcohol use disorder. However, few clinical studies have elucidated the significance, mechanisms, and therapeutic options of alcohol-related myopathy. Preclinical studies indicate that alcohol adversely affects both anabolic and catabolic pathways of muscle-mass maintenance and that an increased proinflammatory and oxidativ...
متن کاملDiabetic Myopathy and Mechanisms of Disease
Humans build muscle mass over the first two decades of life; begin to lose muscle mass and strength between the third and fourth decades, and the decline accelerates during the sixth decade [1,2]. Sarcopenia and dynapenia are age-related loss of skeletal muscle mass and muscle strength, respectively [1–3]. Loss of muscle mass and strength are associated with a reduction in vitality, manifested ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rational Pharmacotherapy in Cardiology
سال: 2012
ISSN: 2225-3653,1819-6446
DOI: 10.20996/1819-6446-2012-8-3-469-473